stars 1 stars 2 stars 3

Inhalio is pioneering the Digital Scent AI Platform — the intelligent revolution of scent and human interactions. Scent That Reads You. Adapts to You. Restores You. We’ve developed a patented SaaS platform with a Nespresso-style infusion model, powered by AI-driven adaptive dosing and biometric feedback. Our technology senses context, reads human states through signals like heart-rate variability, and delivers precise micro-doses of scent exactly when needed — to support emotion, focus, calm, wellness, and performance. From automotive cabins and rideshare fleets to smart homes and health-focused environments, Inhalio transforms passive fragrance into responsive, deeply personal experiences. We license our complete platform — including dry-air diffusion, intelligent cartridges, cloud control, and AI engine — to fragrance brands, automotive partners, smart-home platforms, and wellness innovators. The result: new recurring revenue streams, stronger consumer engagement, and meaningful improvements in how people feel every day. Founded in 2012 and headquartered in Scotts Valley, California, Inhalio is leading the Digital Scent transformation across mobility, connected living, and health & wellness markets. We’re actively scaling through strategic licensing partnerships. Interested in bringing intelligent, adaptive scent to your products or platforms? Let’s talk. #DigitalScent #AIWellness #ScentTech #SmartHome #AutomotiveTech #BiometricAI #finefragrance

Website http://www.inhalio.com
Revenue $1 million
Employees 2 (1 on RocketReach)
Founded 2004
Phone +33 2 99 19 59 59
Technologies
Industry Advertising Services, Advertising, Other Commercial Services, Sales and Marketing, Other Services (B2C Non-Financial), Marketing
Keywords Scent Technology, Mood Enhancement, Wellness Technology, Fragrance Technology, Air Quality, Sensory Experience, Aromatherapy, Health And Wellness, Wellbeing Solutions, Scented Environments, Environmental Wellbeing, Ambient Scent, Sensory Marketing
Competitors Aerogen, PARI Pharma GmbH, Philips, OMRON Healthcare, Inc., BD, Medtronic, Pulmonx Corporation, HILL-ROM B.V., GSK, Teva Pharmaceuticals +37 more (view full list)

Exhalia Questions

The Exhalia annual revenue was $1 million in 2026.

1 people are employed at Exhalia.

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users